Logo image of RVMD

REVOLUTION MEDICINES INC (RVMD) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:RVMD - US76155X1000 - Common Stock

117.69 USD
+1.47 (+1.26%)
Last: 1/21/2026, 3:21:08 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
RVMD revenue by date.RVMD revenue by date.
29.39M
-31.62%
35.38M
20.38%
11.58M
-67.27%
306K
-100.00%
4.22M34.375M
714.57%
211.51M
515.30%
735.28M
247.63%
1.628B
121.41%
2.984B
83.29%
4.589B
53.79%
6.024B
31.27%
7.195B
19.44%
EBITDA
YoY % growth
RVMD ebitda by date.RVMD ebitda by date.
-183.86M
-71.80%
-253.24M
-37.74%
-481.075M
-89.97%
-673.512M
-41.74%
-1.148B
-68.30%
-1.394B
-21.43%
-1.46B
-4.77%
-802.633M
45.03%
-385.637M
51.95%
957.93M
348.40%
2.661B
177.79%
3.557B
33.67%
4.196B
17.96%
EBIT
YoY % growth
RVMD ebit by date.RVMD ebit by date.
-188.01M
-69.84%
-258.28M
-37.38%
-487.185M
-88.63%
-680.641M
-41.53%
-1.152B
-67.05%
-1.291B
-12.11%
-1.161B
10.07%
-746.075M
35.76%
-26.614M
96.43%
971.13M
3,748.94%
2.162B
122.63%
3.074B
42.18%
3.805B
23.78%
Operating Margin
RVMD operating margin by date.RVMD operating margin by date.
-639.71%-730.02%-4,207.12%-222,431.83%-27,294.78%-3,756.54%-549.05%-101.47%-1.63%32.54%47.11%51.03%52.88%
EPS
YoY % growth
RVMD eps by date.RVMD eps by date.
-2.56
-19.63%
-3.10
-21.09%
-3.77
-21.71%
-3.54
5.38%
-5.71
-59.96%
-6.54
-14.49%
-6.01
8.05%
-3.59
40.30%
-0.17
95.20%
4.32
2,609.59%
9.48
119.36%
13.16
38.76%
16.10
22.34%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-1.62
-44.29%
-1.69
-49.65%
-1.76
-34.09%
-1.79
-11.37%
-1.73
-6.90%
-1.58
6.51%
-1.51
14.06%
-1.44
19.79%
-1.36
21.47%
Revenue
Q2Q % growth
3.972M9.871M
148.51%
20.4M40.8M61.2M73.114M
640.69%
EBITDA
Q2Q % growth
-319.257M
-52.99%
-341.936M
-47.21%
-354.153M
-42.28%
-363.179M
-17.55%
-361.223M
-13.14%
-327.614M
4.19%
-311.498M
12.04%
-298.768M
17.74%
-288.344M
20.18%
EBIT
Q2Q % growth
-324.835M
-50.17%
-336.18M
-52.60%
-345.39M
-44.14%
-352.316M
-11.75%
-343.152M
-5.64%
-328.858M
2.18%
-312.793M
9.44%
-296.82M
15.75%
-289.425M
15.66%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-1.61
-71.28%
-1.45-0.16-11.24%
Q2 2025
Q2Q % growth
-1.31
-61.73%
-1.16-0.15-12.79%
Q1 2025
Q2Q % growth
-1.13
-61.43%
-1.11-0.02-1.54%
Q4 2024
Q2Q % growth
-1.12
1.75%
-1.01-0.11-11.25%
Q3 2024
Q2Q % growth
-0.94
5.34%
-0.91-0.03-3.17%
Q2 2024
Q2Q % growth
-0.81
11.96%
-0.79-0.02-2.48%
Q1 2024
Q2Q % growth
-0.70
2.78%
-0.760.068.02%
Q4 2023
Q2Q % growth
-1.14
-80.95%
-0.90-0.24-26.70%
Q3 2023
Q2Q % growth
-0.99
-14.14%
-1.030.033.23%
Q2 2023
Q2Q % growth
-0.92
-12.20%
-0.84-0.08-9.49%
Q1 2023
Q2Q % growth
-0.72
7.69%
-0.830.1113.23%
Q4 2022
Q2Q % growth
-0.63
11.27%
-0.840.2124.84%
Q3 2022
Q2Q % growth
-0.87
-20.83%
-0.86-0.01-1.27%
Q2 2022
Q2Q % growth
-0.82
-36.67%
-0.870.055.39%
Q1 2022
Q2Q % growth
-0.78
-47.17%
-0.790.011.31%
Q4 2021
Q2Q % growth
-0.71
-36.54%
-0.65-0.06-9.01%
Q3 2021
Q2Q % growth
-0.72
-71.43%
-0.64-0.08-12.86%
Q2 2021
Q2Q % growth
-0.60
-30.43%
-0.57-0.03-5.04%
Q1 2021
Q2Q % growth
-0.53
28.38%
-0.530.000.84%
Q4 2020
Q2Q % growth
-0.52 -0.39-0.13-32.76%
Q3 2020
Q2Q % growth
-0.42 -0.40-0.02-5.04%
Q2 2020
Q2Q % growth
-0.46 -0.37-0.09-24.58%
Q1 2020
Q2Q % growth
-0.74 -0.34-0.40-118.19%
RVMD Yearly EPS VS EstimatesRVMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5 10 15
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
1.613M-1.613M-100.00%
Q2 2025
Q2Q % growth
2.867M-2.867M-100.00%
Q4 2024
Q2Q % growth

-100.00%
353.073K-353.073K-100.00%
Q3 2024
Q2Q % growth
327.859K-327.859K-100.00%
Q2 2024
Q2Q % growth

-100.00%
765K-765K-100.00%
Q1 2024
Q2Q % growth

-100.00%
1.404M-1.404M-100.00%
Q4 2023
Q2Q % growth
742K
-95.16%
1.113M-371K-33.33%
Q3 2023
Q2Q % growth

-100.00%
765K-765K-100.00%
Q2 2023
Q2Q % growth
3.824M
-58.07%
1.594M2.23M139.90%
Q1 2023
Q2Q % growth
7.014M
-7.47%
2.996M4.018M134.11%
Q4 2022
Q2Q % growth
15.33M
62.05%
7.908M7.422M93.85%
Q3 2022
Q2Q % growth
3.36M
205.45%
6.406M-3.046M-47.55%
Q2 2022
Q2Q % growth
9.12M
4.83%
7.159M1.961M27.39%
Q1 2022
Q2Q % growth
7.58M
-25.17%
8.67M-1.09M-12.57%
Q4 2021
Q2Q % growth
9.46M
8.11%
9.096M364K4.00%
Q3 2021
Q2Q % growth
1.1M
-91.31%
8.874M-7.774M-87.60%
Q2 2021
Q2Q % growth
8.7M
-13.26%
9.571M-871K-9.10%
Q1 2021
Q2Q % growth
10.13M
-12.29%
9.649M481K4.98%
Q4 2020
Q2Q % growth
8.75M 17.116M-8.366M-48.88%
Q3 2020
Q2Q % growth
12.66M 14.525M-1.865M-12.84%
Q2 2020
Q2Q % growth
10.03M 13.627M-3.597M-26.40%
Q1 2020
Q2Q % growth
11.55M 13.643M-2.093M-15.34%
RVMD Yearly Revenue VS EstimatesRVMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS1.5% -3.51% 0% -5.48%
Revenue34.87% 100.1% 0% -2.09%